Autres langues Repare Therapeutics Inc.

Actions

RPTX

US7602731025

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 28/05/2024			Varia. 5j.	Varia. 1 janv.
3,26 ^USD	+4,49 %		-4,12 %	-55,34 %

08/05	Les plus fortes hausses du prémarché	MT
07/05	Repare Therapeutics Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Top Premarket Gainers	08/05
Repare Therapeutics Shares Rise Premarket Wednesday After Company Swings to Q1 Net Income Amid Higher Revenue	08/05
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results	07/05
Repare Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
DEBIOPHARM AND REPARE THERAPEUTICS ANNOUNCE FIRST PATIENT DOSED IN PHASE 1/1B MYTHIC TRIAL EVALUATING THE SYNTHETIC LETHAL COMBINATION OF WEE1 AND PKMYT1 INHIBITION	01/05
Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition	30/04
Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition	30/04
Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1B Mythic Trial Evaluating the Synthetic Lethal Combination of Wee1 and Pkmyt1 Inhibition	30/04
Repare Therapeutics Inc. Announces Directorate Changes	26/04
Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors	26/04
Repare Therapeutics Inc. (RPTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	21/03
Repare Therapeutics Inc. (RPTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	15/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX	12/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX	03/03
Repare Therapeutics to Participate in Two Upcoming Investor Conferences	29/02
Repare Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	28/02
Repare Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX	24/02
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Repare Therapeutics Inc. (RPTX)	17/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Repare Therapeutics Inc.

Actions

RPTX

US7602731025

Autres langues

Filtres